Patria Investments Limited (PAX): A Bear Case Theory

Core Thesis - A bearish thesis on Patria Investments Limited (PAX) highlights significant operational and financial concerns, suggesting the company may be overstating performance and masking losses [1][2][8] Financial Performance - As of February 9th, PAX's share price was $14.57, with trailing and forward P/E ratios of 20.91 and 8.14 respectively [1] - The firm has approximately USD 50 billion in assets under management (AUM) [2] Investment Concerns - Key holdings are distressed, with a pharmaceutical distributor valued at 15x EV/EBITDA despite bonds trading near 50 cents on the dollar, and other investments like a loss-making hospital chain marked at multiples above market norms [3] - Many positions are supported by off-balance-sheet loans and fund-level guarantees, which delay loss recognition and increase limited partner (LP) exposure [3] Governance and Operational Risks - Patria appears to sustain performance fees through circular internal transactions and questionable exits, raising concerns about governance [4] - The firm has experienced a CFO resignation, an unexplained auditor change, high employee turnover, and the exit of Blackstone's 40% stake, which removed prior external validation [5] Financial Engineering and Sustainability - The reliance on debt, deferred payments, and synthetic earnings to support AUM growth and share buybacks raises risks regarding dividend sustainability, especially in a high-interest Brazilian macro environment [6] - PAX's valuation appears stretched, with a 3.5% yield offering limited upside relative to the structural and operational risks faced by investors [6]